Page 40 - P4304.1-V96_PS-Magazine-April 2024
P. 40

Top Tips









           Ventolin Evohaler Alternatives

           Unfortunately, we need to let members know that as of 31  March 2024, Ventolin
                                                                             st
           (Salbutamol) Evohaler will be removed from the GSK scheme.
           All other products, including; Avamys (Fluticasone) Nasal Spray, the Dermovate
           (Clobetasol) range, Lamictal (Lamotrigine) Tablets and the entire Ellipta range remain
           on the scheme.
           There are however, a couple of profitable alternatives that you may want to consider
           using, with both Salamol and generic Salbutamol being profitable prescribing choices.


                                          DT   NHS   MDS        Total   NETT   DT      NHS   Prescribed   Prescribed
           Supplier  PIP Code  Product Description        WS %
                                         Price  Price  %         %    Price*  Clawback Clawback Generically  By Brand
                          Ventolin 100mcg
                            Metered Dose
            GSK   2456051                £1.50 £1.50  0%  0%    0%    £1.50   £0.17   £0.17   -£0.17   -£0.17
                           Evohaler (200
                               Dose)
                          Salamol 100mcg
            Teva  2635225   Metered Dose   £1.50 £1.46    APM         £1.17   £0.17   £0.16    £0.16    £0.13
                            Inhaler (200
                               Dose)
                            Salbutamol
                          100mcg Metered
            APM   5022926                £1.50 £1.50      APM          1.31   £0.17   £0.17    £0.02    £0.02
                            Dose  Inhaler
                             (200 Dose)
           *Please note APM prices are correct at time of publish and may change without prior notice



           Generic Testosterone Launch
           The time it is taking for newly launched generics to be added to Category M, and
           subsequently having their reimbursement price cut is reducing.
           Which is why maximising on the profit available on a brand new generic launch is a
           great way to improve your practice’s profitability.
           This month generic Testosterone Solution for Injection became available and is a great
           example of how moving from buying a brand to a generic can benefit you.
           The newly launched generic can make your practice £9.62 profit per pack, whereas the
           brand is a loss-making line due to the limited discount currently available.
           Around 80% of prescriptions are written by the brand name, so your practice may
           need to update your systems to take advantange of the profitability of the generic.

                                                                                        NETT   NHS     Profit
             Supplier  PIP Code      Product Description   NHS Price  Rebate  WD  Total %  Price*  Clawback Per Pack
              APM    6784748  Testosterone 250mg/ml Soluion for   £87.11   APM         £67.75  £9.74   £9.62
                                     Injection (1 x 4ml)
                              Nebido 250mg/ml Soluion for Injection
            Grunenthal  -                                   £87.11  0%     4%     4%   £83.63  £9.74  -£6.25
                                         (1 x 4ml)
                              Nebido 250mg/ml Soluion for Injection
               PI    8863367                                £87.11          PI         £87.10  £9.74  -£9.73
                                         (1 x 4ml)









         40    PS Magazine | Top Tips                                                Buy direct online at PSUK.co.uk
   35   36   37   38   39   40   41   42   43   44   45